Old Web
English
Sign In
Acemap
>
authorDetail
>
Robert J. Turner
Robert J. Turner
Novartis
Agonist
Chemistry
Biochemistry
Indacaterol
Salmeterol
4
Papers
215
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
In Vitro and in Vivo Pharmacological Characterization of 5-[(R)-2-(5,6-Diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (Indacaterol), a Novel Inhaled β2 Adrenoceptor Agonist with a 24-h Duration of Action
2006
Journal of Pharmacology and Experimental Therapeutics
Cliff Battram
Steven J. Charlton
Bernard Cuenoud
Mark R. Dowling
Robin Alec Fairhurst
David Farr
John R. Fozard
Juliet Leighton-Davies
Christine Lewis
Lorraine McEvoy
Robert J. Turner
Alexandre Trifilieff
Show All
Source
Cite
Save
Citations (154)
Assessing the minimum number of data points required for accurate IC50 determination.
2005
Assay and Drug Development Technologies
Robert J. Turner
Steven J. Charlton
Show All
Source
Cite
Save
Citations (18)
1